Isocitrate dehydrogenase inhibitors in acute myeloid leukemia
Abstract Isocitrate dehydrogenase (IDH) is a key enzyme involved in the conversion of isocitrate to α-ketoglutarate (α-KG) in the tricarboxylic acid (TCA) cycle. IDH mutation produces a neomorphic enzyme, which can lead to the abnormal accumulation of R-2-HG and promotes leukemogenesis. IDH mutation...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2019-10-01
|
| Seri Bilgileri: | Biomarker Research |
| Konular: | |
| Online Erişim: | http://link.springer.com/article/10.1186/s40364-019-0173-z |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|